Skip to content

The Role and Mechanisms of m ⁶ A RNA Methylation in Tumorigenesis and Functional Regulation

· 0 citations · 20 references

TL;DR

It is shown that aberrant m ⁶ A modification is widely involved in the development of various tumors by regulating the expression of oncogenes and tumor suppressor genes, thereby influencing malignant phenotypes such as tumor proliferation, metastasis, metabolic reprogramming, immune evasion, immune evasion, and drug resistance.

View source

Similar papers

Review Open access Sep 2026

The role and clinical impact of aberrant m6A RNA modification in cancer

This review systematically dissects how dysregulated m6A methylation fuels malignant transformation and progression by reinforcing core oncogenic hallmarks, sustained proliferation, metastasis, metabolic rewiring, and resistance to programmed cell death.

Sheng-Jie Tang, Rangping Xie, Jiang Fu et al. · 0 citations
Review Open access Jul 2026

Role of m6A RNA Methylation in T Cell Biology and Immunotherapy

This review focuses on the interplay between immunity and epitranscriptomics and explores the direct and indirect effects of m6A modification on T cells and highlights the pivotal role of m6A regulation in T cell biology and its potential to optimize next-generation immunotherapies.

Yumna A. Butt, Nordin D. Zandhuis, I. Foskolou · 0 citations
Review Sep 2026

Regulation of cancer redox metabolism by mutant p53.

The tumor suppressor protein p53 is an often-mutated transcriptional factor in metastatic malignancies. The mutations result in the protein acquiring new oncogenic capabilities and/or losing canonical suppressor functions, either way contributing to cancer growth and resistance to conventional radio- and chemo-therapy....

Jorge Luis Vargas-Navarro, Joaquín Alberto Padilla-Flores, Juan Carlos Granados-Rivas et al. · 0 citations
Review 2026

Biological roles and clinical potential of piRNAs in cancer: Insights into glioblastoma

Non-coding RNAs serve as key regulators of gene expression at both the transcriptional and post-transcriptional levels. Among them, piRNAs, a class of small non-coding RNAs, have emerged as significant mediators in cancer biology. PIWI proteins, members of the Argonaute family highly expressed in germline cells, intera...

A. Nakhaei, A. Omidkhoda, Farzaneh Abbasinezhad-Moud et al. · 0 citations
Review Sep 2026

Reciprocal regulation of m6A RNA methylation and protein post-translational modifications: implications for disease pathogenesis and therapy.

A framework for understanding the regulatory networks of m6A-PTMs crosstalk in disease pathogenesis, development, and therapeutic response is provided, highlighting potential treatment strategies based on this interplay and suggesting future research directions.

Xinyi Li, Li-Ting Yang, Xian-Min Zhou et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.